LncRNA editing could induce major histocompatibility complex I and tumor immunogenicity in the tumor cell membrane to encapsulate anti-TIM-3, thereby forming LCCT nanoparticles, which were embedded in an alginate-based hydrogel to suppress postsurgical tumor relapse. This evidence concerns the gene HAVCR2 and neoplasm.